MyFinsight
Home
Blog
About
Proceeds from exercise of
stock options
$3,793K
(-31.67%↓ Y/Y)
Stock-based compensation
expense
$18,176K
(-62.43%↓ Y/Y)
Accrued compensation
$7,869K
(267.71%↑ Y/Y)
Depreciation and
amortization
$6,778K
(-64.04%↓ Y/Y)
Accounts payable
$3,039K
(-68.40%↓ Y/Y)
Accrued expenses and
other liabilities
$2,860K
Other non-cash
adjustments
-$161K
(91.80%↑ Y/Y)
Other non-current
assets
-$114K
(-118.91%↓ Y/Y)
Net cash provided by
financing activities
$3,787K
(-83.51%↓ Y/Y)
Net cash used in
operating activities
$1,115K
(103.11%↑ Y/Y)
Effect of exchange
rates on cash, cash...
$10K
(150.00%↑ Y/Y)
Canceled cashflow
$6K
Canceled cashflow
$37,882K
Net decrease in
cash, cash...
-$5,286K
(79.05%↑ Y/Y)
Canceled cashflow
$4,912K
Proceeds from maturity of
investments
$12,800K
(-55.82%↓ Y/Y)
Repurchases of common stock
for income tax...
$6K
(-57.14%↓ Y/Y)
Net loss
-$35,051K
(30.64%↑ Y/Y)
Inventories
$1,647K
(-11.50%↓ Y/Y)
Accounts receivable, net
$1,085K
(-92.85%↓ Y/Y)
Prepaid expenses and
other current assets
$99K
(-94.57%↓ Y/Y)
Net cash used in
investing activities
-$10,198K
(17.49%↑ Y/Y)
Canceled cashflow
$12,800K
Purchases of investments
$13,235K
(-53.16%↓ Y/Y)
Purchases of property and
equipment
$9,763K
(-37.32%↓ Y/Y)
Back
Back
Cash Flow
Twist Bioscience Corp (TWST)
Twist Bioscience Corp (TWST)
source: myfinsight.com